Clinical Trial Update: A Study of TAK-279 in Adults With or Without Liver Damage [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study of TAK-279 in adults with hepatic impairment or in healthy volunteers that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• TAK-279

Snippet

Sponsor: Takeda | Conditions: Hepatic Impairment, Healthy Volunteers | Phase 1 | Status: COMPLETED